Lung Foundation Australia is teaming with researchers, doctors and patients Australia-wide today, during Pneumonia Awareness Week (13-20 May), to call for proactive community action to address the declining vaccination rates against pneumococcal pneumonia – an infection responsible for more than 15,000 GP visits, 8,000 hospitalisations, and 2,000 deaths among those aged over 65 each year. Their…

Read More

Team VIVA! wins PR campaign of the year at 2012 PRIME Awards VIVA! Communications, together with client, CSL Biotherapies, clinched PR Campaign of the Year at the highly prestigious 2012 PRIME Awards held at The Westin Hotel, Sydney on  Thursday, September 20. The PRIME judging panel rated our campaign, ‘Protecting Against Pneumococcal Pneumonia,’ the “stand-out”…

Read More

Administering the pneumococcal pneumonia and seasonal influenza vaccines together is a potential strategy to increase pneumococcal immunisation rates, and prevent additional hospitalisations and mortality in the elderly and other high-risk groups, according to a new article published in the American Journal of Public Health. Pneumonia is a serious and potentially fatal disease that is often…

Read More